News | March 14, 2011

Michigan Hospital Performs Robotic Heart Procedure for Atrial Fibrillation


March 14, 2011 – Doctors at Beaumont Hospital in Troy, Mich., have performed the state’s first minimally invasive robotic procedure to correct atrial fibrillation. The new robotic maze procedure is an alternative to open-heart surgery. It's performed through tiny, keyhole incisions with fewer complications and a shorter hospital stay.

Phillip Robinson, M.D., cardiovascular surgeon, Brian Williamson, M.D. and Ilana Kutinsky, D.O., both electrophysiology cardiologists, performed the robotic-assisted maze procedure on March 2 on a 66-year-old woman. The robotic approach allows for smaller incisions and greater precision.

A maze procedure is a surgical treatment for atrial fibrillation that is used to stop an irregular heartbeat and restore a normal heart rhythm. Patients are candidates for a maze procedure if their irregular heartbeat cannot be treated with medication or other nonsurgical approaches.

"This new robotic maze procedure allows us to correct an electrical irregularity in the heart without having to perform open-heart surgery," Robinson said. "We don't have to open the patient's chest, stop the heart or place the patient on a heart-lung machine. As a result, patients have fewer complications, less risk of infection, a shorter hospital stay and a quicker recovery."

With the procedure, the surgeon makes five tiny incisions the size of a dime in the patient's chest, inserting a small endoscopic robotic camera to view the outer surface of the heart. The surgeon sits at a console viewing 3-D images from the robotic camera, while directing robotic arms with their attached surgical instruments. A device is then passed through the tiny incisions to ablate or destroy areas of heart tissue, creating a scar that will block the conduction of abnormal electrical impulses and create a pathway, or maze, for normal electrical signals to travel to the heart's lower chambers (ventricles).

"This procedure combines the specialized skills and expertise of a cardiovascular surgeon and an electrophysiology cardiologist to provide a new treatment option benefiting AF patients," Kutinsky said.

The procedure takes approximately two to three hours. Most patients are able to go home within two to three days after the procedure.

Candidates include those who cannot tolerate drugs, such as blood thinners; patients whose quality of life is limited by drugs; those who continue to slip into an irregular heart rhythm; and those who cannot have catheter ablation or have had it, but still have AF symptoms.

Atrial fibrillation is an irregular rhythm of the heart's upper chambers (atria) causing the heart to quiver in a fast, uncontrolled manner. As a result, blood is not pumped completely out of the atria and may pool or clot. If a blood clot leaves the heart and becomes lodged in an artery in the brain, a stroke may occur. About 15 percent of strokes occur in people with atrial fibrillation.

For most people with atrial fibrillation, slowing heart rate with medications is the most appropriate treatment. AF patients can also be treated with electrical cardioversion (restoring heart rhythm with an electrical shock); radiofrequency ablation (destroying heart tissue with radiofrequency energy); or through traditional open-heart maze surgery. Patients with atrial fibrillation should also take blood thinners to prevent stroke, unless they have a condition that would make use of blood thinners dangerous.

For more information: www.heart.beaumonthospitals.com


Related Content

News

April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...

Home April 29, 2026
Home
News

April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...

Home April 27, 2026
Home
News

April 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation ...

Home April 27, 2026
Home
News

April 13, 2026 — Johnson & Johnson has announced favorable 12-month interim effectiveness and safety results from ...

Home April 13, 2026
Home
News

In a milestone for Broward Health in Ft. Lauderdale, Fla., Jose L. Baez-Escudero, M.D., chief of cardiology and ...

Home March 24, 2026
Home
News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
Feature | Kyle Hardner

Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...

Home January 09, 2026
Home
News

Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...

Home January 06, 2026
Home
Subscribe Now